Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News US Stem Cell Inc USRM

Healthcare Biotechnology
U.S. Stem Cell, Inc. is a biotechnology company. The Company is focused on the discovery, development and subject to regulatory approval and commercialization of autologous cell therapies for the treatment of chronic and acute heart damage. The Company's product candidates are MyoCell, MyoCell SDF-1 and Adipocell. MyoCell and MyoCell SDF-1 product candidates are clinical therapies designed to... see more

Recent & Breaking News (GREY:USRM)

Court Reports Favorable Judgment in California Stem Cell Case

Accesswire September 1, 2022

Mark Borman Appointed Chairman of the Board of USRM

Accesswire March 9, 2022

USRM to Focus on Animal Health and Lead Pet-Care Innovation

Accesswire October 18, 2021

US Stem Cell Inc Reports Legal Appeal Results and Company Direction

Accesswire June 8, 2021

Northstar Biotech and USRM BOD Members Reinvest in the Company

Accesswire February 23, 2021

USRM Oral Argument in Appeal from FDA Enforcement Action

Accesswire January 19, 2021

U.S. Stem Cell Confirms Date for Appeals Court Oral Arguments

Accesswire September 30, 2020

Corrected: USRM Posts Earnings for Second Quarter 2019

PR Newswire August 9, 2019

USRM Posts Earnings for Second Quarter 2019

PR Newswire August 7, 2019

USRM Posts Financial Results for First Quarter 2019

PR Newswire May 7, 2019

Dr. Comella to Present at Paleo f(x) Conference in Austin, Texas

PR Newswire April 26, 2019

USRM Posts Increase in Revenue and Profit Margin for 2018

PR Newswire March 13, 2019

USRM Chief Science Officer Featured on One Radio Network

PR Newswire January 15, 2019

Dr. Kristin Comella Featured on Robert Scott Bell Show

PR Newswire November 9, 2018

USRM Posts 25% Nine Month Revenue Increase From 3Q 2017

PR Newswire November 7, 2018

Adipose Stem Cells Demonstrate Effectiveness in Repairing Decubitus Ulcers

PR Newswire October 9, 2018

USRM Chief Science Officer Featured on YourVoice™ America

PR Newswire October 1, 2018

Dr. Kristin Comella Joins Top Docs in Fix for Female Hormones Seminar

PR Newswire September 26, 2018

USRM Hires Senior VP of US & International Sales

PR Newswire September 11, 2018

USRM Posts Profitable Results for Second Quarter 2018

PR Newswire August 8, 2018